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Background: The interaction of periodontopathic bacteria with host immune system induces the production of in-
flammatory mediators which leads to alveolar bone loss (ABL), the essential feature of periodontitis. Concurrently, 
periodontal diseases cause the elevation of blood cytokine levels, the alteration of gut microbiota and the disse-
mination of enterobacteria to the liver. Owing to these mechanisms, periodontal disease might be a risk for liver 
dysfunction. Several epidemiological studies have reported associations between periodontal diseases and liver 
dysfunction, although the association between ABL and liver dysfunction has not been investigated. This cross-sec-
tional study determined if elevated serum liver enzyme levels were associated with ABL in Japanese adults.
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Introduction
Periodontal diseases are chronic inflammatory diseases 
in which periodontal tissues are destroyed by Gram-ne-
gative anaerobic bacteria such as Porphyromonas gin-
givalis (1). Periodontal pathogens are released from the 
sulcus into the bloodstream, and lead to transient bacte-
remia (2). The virulence factors of periodontal bacteria, 
including lipopolysaccharide (LPS), antigens, and exoto-
xins, interact with the host immune system inducing the 
production of inflammatory mediators, tumor necrosis 
factor-α (TNF-α), interleukin-1β (IL-1β), interleukin-6 
(IL-6), receptor activator of nuclear factor kappa-B li-
gand (RANKL), and prostaglandin E2 (3-5). Owing to 
these mechanisms, periodontal diseases are thought to 
be associated with several systemic diseases including 
atherosclerosis, cardiovascular diseases, hyperlipidemia 
and rheumatoid arthritis (6-9).  
In animal studies, periodontitis induced by nylon ligatu-
re or oral administration of LPS in rats caused decreased 
pericytes and liver steatosis (10,11). Periodontitis-indu-
ced rats receiving tooth brushing showed reduced serum 
LPS concentration and suppressed hepatic inflammation, 
steatosis and 8-hydroxydeoxyguanosin levels (12). In 
other reports, oral administration of P. gingivalis in mice 
induced altered gut microbiota and dissemination of en-
terobacteria to the liver as well as inflammatory changes 
in various tissues and organs (13,14). A cohort study in 
Japan suggested that infection with high-virulence P. 
gingivalis might be a risk factor for the contraction/pro-
gression of non-alcoholic fatty liver disease (15). The 
presence of periodontal pockets was associated with 
serum levels of gamma-glutamyltransferase (GGT) in 
Japanese adults independent of alcohol ingestion (16). 
Periodontal condition was associated with alanine ami-
notransferase (ALT) levels in Japanese men (17,18). 
Combined, these reports have shown the associations of 
periodontal diseases with hepatic metabolism.
Material and Methods: Japanese adults living on Sado Island who visited Sado General Hospital were invited to 
participate in the study. Participants over 40 years of age who underwent dental panoramic radiography and blood 
tests were included. Drinking and smoking habits were self-administered. After excluding patients with edentulous 
jaw, diagnosed liver diseases, and those on dialysis, data from 44 men and 66 women with a mean age of 73 years 
were analyzed. The average percentage of ABL for each participant was calculated for mesial and distal sites of all 
remaining teeth. The levels of serum aspartate aminotransferase (AST), alanine aminotransferase (ALT) and gam-
ma-glutamyltransferase (GGT) were determined. Univariate analyses were performed to select covariates to be put in 
multivariate analyses. The association between elevated serum liver enzyme levels and the highest quartile of ABL 
were assessed by multiple logistic regression analysis.
Results: After adjusting for covariates, no significant association was found between elevated serum AST, ALT, or 
GGT levels as dependent variables and the highest quartile of ABL as an explanatory variable. 
Conclusions: There was no significant association between the elevation of serum liver enzyme levels and ABL in 
Japanese adults. 
Key words: Liver enzymes, dental panoramic radiography, alveolar bone loss, Japanese adults.
Few reports have evaluated alveolar bone loss (ABL) as 
an indicator of periodontal diseases. Therefore, the pre-
sent study assessed the association between the eleva-
tion of serum liver enzymes and ABL in Japanese adults 
living on Sado Island.
Material and Methods
-Participants
The Project in Sado for Total Health (PROST) is exe-
cuted in Sado Island, Niigata Prefecture Japan. The 
population was nearly 57,000 as of October 2015. The 
PROST is a hospital-based cohort study of outpatients 
of Sado General Hospital that began in June 2008. In 
the current study, 2,530 individuals between 21 and 
102 years of age joined the PROST as of May 2015. All 
participants underwent a general physical examination, 
blood test, and interviews for health check from 2008 to 
2015. The participants visited the department of dentis-
try in the hospital and underwent panoramic radiography 
for dental treatments from 2003 to 2015. The average 
interval between panoramic radiographs and blood tests 
was 866 days. History of illness was corrected from cli-
nical record. The study inclusion and exclusion criteria 
are shown in Figure 1. Systematic disease was not con-
sidered expect of liver dysfunction. The people who are 
diagnosed of “hepatitis B, hepatitis C, hepatoma” were 
defined as “Liver dysfunction group” A total of 110 par-
ticipants were finally included in the study. Informed 
consent was obtained from each participant. We have 
obtained consent to publish from the participant to re-
port individual patient data. The medical ethics commi-
ttee of Niigata University approved the study protocol 
(approval number 511).
-Radiographic analysis
ABL was measured using panoramic radiography (19). 
We calculated the distance from the cement-enamel 
junction (CEJ) to the alveolar crest (AC) and the total 
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Fig. 1: Participant’s flowchart. Exclusion criteria were under 40 years old, absent a pan-
oramic radiograph before the blood test, edentulous jaw, dialysis patients and have liver 
disfunction. * The people who are diagnosed of “hepatitis B, hepatitis C, and hepatoma” 
were defined as “Liver dysfunction group”. 
root length (CEJ-apex) of each remaining tooth at two 
sites (mesial and distal) using Image J software (Ras-
band, W.S., ImageJ, U. S. National Institutes of Health, 
Bethesda, Maryland, USA). The apex was defined as the 
most apically located point of the tooth. In teeth resto-
red with fillings or crowns, the most apical limit of the 
restoration was considered equivalent to the CEJ and 
taken as the reference point. ABL was measured as the 
percentage of the distance between the CEJ-AC and the 
CEJ-apex (20). The measurements were made for all re-
maining teeth including the third molars.  Residual roots 
without a cap for overdenture were excluded. Tooth with 
caries or periapical lesion was not excluded. Data were 
collected by four dentists who were calibrated prior to 
the study using 10 panoramic radiographs (Cronbach al-
pha coefficient = 0.73). We divided the participants into 
quartiles according to individual average ABL values.
-Blood test data
Serum concentrations of ALT, aspartate aminotransfera-
se (AST), and gamma-glutamyltransferase (GGT) were 
measured. The standard values for each serum liver en-
zymes were based on Japanese Committee for Clinical 
Laboratory Standard guidelines. Elevated levels were 
defined as >30 U/L for AST, >42 U/L in men and >23 
U/L in women for ALT and >64 U/L in men and >32 U/L 
in women for GGT. 
-Covariates
Alcohol consumption, smoking habits, age, blood pres-
sure, and body mass index (BMI) were considered as co-
variates, according to previous studies reporting the risk 
factors for elevated serum liver enzyme levels (16,21-
23). Alcohol drinking and smoking habits were surveyed 
using a self-administered questionnaire. The responses 
for alcohol drinking habits questionnaire were as fo-
llows: (1) “I drink more than 1 day a week, “(2) “I was a 
drinker before,” (3)” I’m a social drinker,” and (4) ” I do 
not drink alcohol at all.”  This study categorized social 
drinkers and past drinkers into the “No drinking habits” 
and “Drinking habits” groups, respectively. Similarly, 
the responses for smoking habits were as follows: (1) 
“I have a smoking habit,” (2)” I had a smoking habit 
before,” and (3) “I do not smoke at all.” Past smokers 
were categorized into the “Have smoking habits” group. 
Age, blood pressure, and BMI were recorded during 
PROST registration. Blood pressure was measured twi-
ce, with average blood pressure ≥140 and/or ≥90 mmHg, 
and/or the use of antihypertensive medication defined as 
hypertension.
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Fig. 2: Histograms of serum liver enzymes by gender.
-Statistical analysis
The participants characteristics (sex, age, number of 
teeth, systolic blood pressure, diastolic blood pressure, 
BMI, drinking habit, smoking habit) according to ABL 
quartiles were evaluated using Mann-Whitney U and 
chi-square tests. Subsequently, we evaluated the univa-
riate association between liver enzyme levels and the hi-
ghest ABL quartile or other variables. Then, with GGT, 
ALT, or AST as the response variables, the associations 
with the highest quartile of ABL were assessed using 
multiple logistic regression analysis. The confounding 
factors were selected based on the results of the univa-
riate analyses. Statistical analyses were performed using 
SPSS Statistics for Windows, version 23.0 (IBM Corp., 
Armonk, New York, USA). 
Results
As figure 2, the liver enzymes values were not normally 
distributed (Kolmogorov-Smirnov test, p>0.05). There-
fore we determined non-parametric test used.
The study participant characteristics are shown in Table 
1. Significant differences were observed between ABL 
quartiles in sex, number of teeth and smoking habit.
Table 2 shows univariate associations of serum liver en-
zymes with the highest quartile of ABL or other risk fac-
tors. We selected the top three variables with the smallest 
p-values as the confounding factors for the subsequent 
multiple logistic regression analysis. As shown in Table 
3, no significant association was observed between the 
highest quartile of ABL and elevation of serum liver en-
zyme levels after adjusting for confounding factors.
Discussion
In this study, we did not find significant association 
between ABL and serum levels of the AST, ALT, and 
GGT liver enzymes in Japanese adults, inconsistent with 
previous studies. The discrepancy might be caused by 
differences in selected parameters of periodontal disea-
ses. Several parameters such as probing depth, clinical 
attachment level, or percentage of bleeding on probing, 
have been used in other studies to assess the possible 
relevance of periodontal diseases to systemic diseases. 
Morita et al. reported the association between perio-
dontal pocket depth ≥4mm and serum GGT levels (16). 
Among the parameters, ABL and clinical attachment 
level represent the result of tissue destruction by perio-
dontitis, which existed in the past (24). They are essen-
tial features of periodontitis; in contrast, pocket depth 
and bleeding on probing are observed even in gingivitis. 
Bone-resorbing cytokines such as IL-1β, TNF-α, IL-6, 
and RANKL are produced in reaction to bacterial infec-
tions and induce ABL (25-27). Since the degree of ABL 
could reflect integrated history of inflammation, it was 
expected to be associated with hepatic dysfunction. The 
results of this study suggest that inflammatory burden by 
periodontitis would be a relatively short-term modulator 
of hepatic function. 
Unlike most previous reports on the relationships be-
tween periodontal diseases and diagnosed hepatic di-
seases (15,28,29), we categorized the participant groups 
using the standard values of serum liver enzymes. These 
markers can be used as a first step in diagnosis of liver 
dysfunction in large-sample surveys. Although some 
previous studies used serum liver enzyme levels, the par-



















(Men / Women) 
44/66 6/21 7/21 15/13 16/11 
Age (year) 
(mean ±SD) 
73.3±9.5 70.2±9.9 72.8±10.9 77.1±6.3 73.1±9.4 
Number of teeth b 
(mean ±SD) 
19.2±7.5 22.2±7.1 21.3±6.6 17.3±6.4 15.8±8.3 
Systolic blood pressure (mmHg) 
(mean ±SD) 
137.1±18.0 134.4±16.0 136.0±16.7 142.3±20.0 135.8±18.8 
Diastolic blood pressure (mmHg) 
(mean ±SD) 
74.7±11.2 74.1±11.7 74.6±12.0 77.9±11.0 72.3±9.7 
BMI (kg/m2) 
(mean ±SD) 
24.7±4.8 25.2±4.8 24.4±5.6 24.2±4.1 25.3±4.9 
Drinking habit 
(Current and previous / Never) 
40/70 9/18 6/22 14/14 11/16 
Smoking habit a 
(Current and previous / Never) 
39/71 4/23 7/21 11/17 17/10 
Table 1: Characteristics of participants.
a: p<0.01, Chi-square test.
b: p<0.05, Mann-Whitney U test.
ticipants were younger than those in this study (16-18). 
Additionally, they used data from health checkups, whe-
reas the present study was hospital-based. Furthermore, 
we found no significant associations between the eleva-
tion of serum liver enzymes and known risk factors such 
as, drinking or smoking habits, sex, obesity, or hyper-
tension after adjusting for other variables. These facts 
suggest that higher age and some potential confounders 
may have concealed relationships between ABL and the 
elevation of serum liver enzymes in this study.
The distributions of the degrees of ABL were skewed 
according to sex, number of teeth, and smoking habit, in 
agreement with the findings of previous reports. Female 
sex, a larger number of teeth, and non-smoking status 
were associated with lower ABL.
We did not collect bacteriological data such as plaque 
index or the presence of periodontopathic bacteria which 
could have been significant confounders. Another limi-
tation of this study was the number of participants. Ad-
ditionally, we could not test the causative relationships 
between ABL and the elevation of serum liver enzymes, 
although the chronological orders were consistent. Lon-
gitudinal studies are needed to improve the understan-
ding of the association between elevated serum liver 
enzymes and periodontal diseases.
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(Men / Women) 
37/53 7/13 0.801 38/47 6/19 0.069 39/51 5/15 0.206 
Age (years) 
(mean ±SD) 
73.2±9.9 74.2±7.7 0.975 74.1±9.4 70.9±9.5 0.075 74.0±9.6 70.5±8.6 0.076 
Number of teeth 
(mean ±SD) 
18.9±7.7 20.2±6.8 0.466 18.7±7.6 20.6±7.2 0.197 18.9±7.4 20.4±8.2 0.183 
ABL quartile 
(Highest / other) 
21/69 6/14 0.570 22/63 5/20 0.609 23/67 4/16 0.776 
Hypertension* 
(High / normal) 




36/54 13/7 0.050 37/48 12/13 0.820 40/50 9/11 1.000 
Drinking habit 
(Current and 
previous / Never) 
32/58 8/12 0.799 32/53 8/17 0.645 33/57 7/13 0.552 
Smoking habit 
(Current and 
previous / Never) 
33/57 6/14 0.617 35/50 4/21 0.031 34/56 5/15 0.315 
 
Table 2: Univariate associations of serum liver enzymes with the highest quartile of ABL or other risk 
factors.
*Hypertension was defined as a blood pressure over 140mmHg and/or 90mmHg, and/or use of antihy-
pertensive medication.
Chi-squire test or Mann-Whitney U test was performed.
 
 




Highest ABL quartile 0.537 1.433 0.457-4.484 
Hypertension* 0.428 0.951 0.225-1.883 
BMI≥25 0.057 2.710 0.972-7.576 





Highest ABL quartile 0.726 1.242 0.368-4.184 
Age 0.062 0.654 0.907-1.002 
Sex 0.866 1.141 0.247-5.267 




Highest ABL quartile 0.942 0.953 0.263-3.451 
Number of teeth 0.790 1.010 0.936-1.091 
Age 0.182 0.963 0.911-1.018 
Sex 0.131 2.422 0.768-7.638 
Table 3: Multiple logistic regression analyses for elevated serum liver enzymes as outcomes.
*Hypertension was defined as a blood pressure over 140mmHg and/or 90mmHg, and/or use of antihypertensive medication.
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